Jiangxi Fushine Pharmaceutical Co.,Ltd.’s Net Profit Dropped 31.7% in First Half of 2021

Jiangxi Fushine Pharmaceutical Co.,Ltd. (江西富祥药业股份有限公司) (300497.SZ) reported a net profit of 151.8 million yuan in the first half of 2021, down 31.7% year-on-year.

Meanwhile, the company posted 775.8 million yuan in revenue, down 5% year-on-year.

At the end of the reporting period, it had 4.3 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 29%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.